ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Zhimin Tong
Matched on OpenAlex author ID A5101057478. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2011: 3 papers
Papers 3
- Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Co-author DOI 10.1002/cncr.25803↗
- Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells. Co-author DOI 10.1002/jcp.22421↗
- Target-specific agents imaging ectopic and orthotopic human pancreatic cancer xenografts. Co-author DOI 10.1097/mpa.0b013e31821f6b14↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sushovan Guha · 3 shared papers, 2011 · strength 0.08
- Paper Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells. DOI 10.1002/jcp.22421↗
- Paper Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-ca… DOI 10.1002/cncr.25803↗
- Paper Target-specific agents imaging ectopic and orthotopic human pancreatic cancer xenografts. DOI 10.1097/mpa.0b013e31821f6b14↗
- Bharat Bhushan Aggarwal · 2 shared papers, 2011 · strength 0.05
- Nobuo Ochi · 1 shared paper, 2011 · strength 0.03
- Yoichi Matsuo · 1 shared paper, 2011 · strength 0.03
- James W. Sinnett‐Smith · 1 shared paper, 2011 · strength 0.03
- Enrique Rozengurt · 1 shared paper, 2011 · strength 0.03
- Subhankar Chakraborty · 1 shared paper, 2011 · strength 0.03
- Sendurai A. Mani · 1 shared paper, 2011 · strength 0.03
- Surinder K. Batra · 1 shared paper, 2011 · strength 0.03
- Sukhwinder Kaur · 1 shared paper, 2011 · strength 0.03
- Robert S. Bresalier · 1 shared paper, 2011 · strength 0.03
- Wei Wang · 1 shared paper, 2011 · strength 0.02
- Ke Shi · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.